25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

IRadimed Corporation
Buy, Hold or Sell?

Let's analyze Iradimed together

I guess you are interested in IRadimed Corporation. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of IRadimed Corporation. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about IRadimed Corporation

I send you an email if I find something interesting about IRadimed Corporation.

1. Quick Overview

1.1. Quick analysis of Iradimed (30 sec.)










1.2. What can you expect buying and holding a share of Iradimed? (30 sec.)

How much money do you get?

How much money do you get?
€0.96
When do you have the money?
1 year
How often do you get paid?
38.1%

What is your share worth?

Current worth
€6.36
Expected worth in 1 year
€7.04
How sure are you?
95.2%

+ What do you gain per year?

Total Gains per Share
€1.61
Return On Investment
2.8%

For what price can you sell your share?

Current Price per Share
€56.50
Expected price per share
€52.50 - €
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Iradimed (5 min.)




Live pricePrice per Share (EOD)
€56.50
Intrinsic Value Per Share
€13.23 - €15.58
Total Value Per Share
€19.59 - €21.94

2.2. Growth of Iradimed (5 min.)




Is Iradimed growing?

Current yearPrevious yearGrowGrow %
How rich?$83.4m$70.3m$7.2m9.4%

How much money is Iradimed making?

Current yearPrevious yearGrowGrow %
Making money$4.6m$4m$575.3k12.4%
Net Profit Margin26.1%25.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Iradimed (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Iradimed?

Welcome investor! Iradimed's management wants to use your money to grow the business. In return you get a share of Iradimed.

First you should know what it really means to hold a share of Iradimed. And how you can make/lose money.

Speculation

The Price per Share of Iradimed is €56.50. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Iradimed.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Iradimed, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €6.36. Based on the TTM, the Book Value Change Per Share is €0.17 per quarter. Based on the YOY, the Book Value Change Per Share is €0.09 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.23 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Iradimed.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.400.7%0.370.7%0.340.6%0.230.4%0.230.4%
Usd Book Value Change Per Share0.300.5%0.170.3%0.090.2%0.120.2%0.310.6%
Usd Dividend Per Share0.160.3%0.240.4%0.270.5%0.310.5%0.290.5%
Usd Total Gains Per Share0.450.8%0.420.7%0.360.6%0.430.8%0.611.1%
Usd Price Per Share45.53-42.53-37.51-31.88-31.33-
Price to Earnings Ratio28.57-29.04-27.70-34.02-33.65-
Price-to-Total Gains Ratio100.74-16.88-102.53-129.43-123.50-
Price to Book Ratio6.92-6.95-6.78-5.89-5.85-
Price-to-Total Gains Ratio100.74-16.88-102.53-129.43-123.50-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share58.4662
Number of shares17
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.240.31
Usd Book Value Change Per Share0.170.12
Usd Total Gains Per Share0.420.43
Gains per Quarter (17 shares)7.067.35
Gains per Year (17 shares)28.2429.38
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
116121821819
2332446421748
3493674632577
465481028434106
5825913010442135
6987115812551164
71148318614659193
81319521416768222
914710724218876251
1016311927020985280

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%20.01.00.095.2%20.01.00.095.2%
Book Value Change Per Share3.01.00.075.0%9.03.00.075.0%17.03.00.085.0%18.03.00.085.7%18.03.00.085.7%
Dividend per Share3.00.01.075.0%6.00.06.050.0%8.00.012.040.0%8.00.013.038.1%8.00.013.038.1%
Total Gains per Share3.01.00.075.0%11.01.00.091.7%19.01.00.095.0%20.01.00.095.2%20.01.00.095.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of IRadimed Corporation compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2870.169+70%0.091+214%0.121+138%0.303-5%
Book Value Per Share--6.3625.922+7%5.368+19%5.157+23%5.099+25%
Current Ratio--9.2138.293+11%8.993+2%10.558-13%10.523-12%
Debt To Asset Ratio--0.1150.147-22%0.147-22%0.142-19%0.143-20%
Debt To Equity Ratio--0.1300.176-26%0.172-25%0.166-22%0.168-23%
Dividend Per Share--0.1500.232-35%0.261-43%0.297-49%0.283-47%
Enterprise Value--547178818.970507897831.926+8%447719345.963+22%379670406.686+44%372915194.309+47%
Eps--0.3850.355+8%0.326+18%0.224+72%0.222+73%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--7.7247.367+5%7.315+6%7.656+1%7.586+2%
Free Cash Flow Per Share--0.4030.338+19%0.094+330%0.179+124%0.179+124%
Free Cash Flow To Equity Per Share--0.2510.098+156%0.086+194%0.077+225%0.077+225%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--15.581--------
Intrinsic Value_10Y_min--13.226--------
Intrinsic Value_1Y_max--0.918--------
Intrinsic Value_1Y_min--0.901--------
Intrinsic Value_3Y_max--3.248--------
Intrinsic Value_3Y_min--3.091--------
Intrinsic Value_5Y_max--6.169--------
Intrinsic Value_5Y_min--5.684--------
Market Cap716047100.000+22%557629600.000520876740.000+7%459410750.000+21%390490266.120+43%383716756.267+45%
Net Profit Margin--0.2760.261+6%0.258+7%0.203+36%0.205+34%
Operating Margin----0%0.148-100%0.116-100%0.124-100%
Operating Ratio--0.9100.930-2%0.936-3%1.024-11%1.022-11%
Pb Ratio8.881+22%6.9166.952-1%6.785+2%5.893+17%5.849+18%
Pe Ratio36.684+22%28.56829.035-2%27.702+3%34.020-16%33.646-15%
Price Per Share56.500+22%44.00041.100+7%36.250+21%30.812+43%30.277+45%
Price To Free Cash Flow Ratio35.071+22%27.31231.761-14%38.766-30%46.144-41%43.947-38%
Price To Total Gains Ratio129.361+22%100.74216.885+497%102.528-2%129.426-22%123.499-18%
Quick Ratio--1.2851.337-4%1.585-19%1.369-6%1.395-8%
Return On Assets--0.0540.051+5%0.049+9%0.035+51%0.036+51%
Return On Equity--0.0610.060+1%0.058+5%0.041+46%0.042+45%
Total Gains Per Share--0.4370.401+9%0.352+24%0.418+5%0.586-25%
Usd Book Value--83435188.05077663820.759+7%70396725.021+19%67629015.050+23%66874037.593+25%
Usd Book Value Change Per Share--0.2970.175+70%0.095+214%0.125+138%0.313-5%
Usd Book Value Per Share--6.5836.128+7%5.555+19%5.336+23%5.277+25%
Usd Dividend Per Share--0.1550.240-35%0.270-43%0.307-49%0.293-47%
Usd Enterprise Value--566220641.870525572676.477+8%463299979.203+22%392882936.838+44%385892643.071+47%
Usd Eps--0.3980.367+8%0.337+18%0.232+72%0.230+73%
Usd Free Cash Flow--5281857.2044438516.159+19%1227621.786+330%2235170.225+136%2128733.547+148%
Usd Free Cash Flow Per Share--0.4170.350+19%0.097+330%0.186+124%0.186+124%
Usd Free Cash Flow To Equity Per Share--0.2600.102+156%0.089+194%0.080+225%0.080+225%
Usd Market Cap740965539.080+22%577035110.080539003250.552+7%475398244.100+21%404079327.381+43%397070099.385+45%
Usd Price Per Share58.466+22%45.53142.530+7%37.512+21%31.884+43%31.331+45%
Usd Profit--5049646.1204656876.555+8%4081529.881+24%2902267.955+74%2880966.882+75%
Usd Revenue--18326521.97317826830.123+3%15743911.888+16%12857444.969+43%12719643.069+44%
Usd Total Gains Per Share--0.4520.415+9%0.365+24%0.432+5%0.606-25%
 EOD+4 -4MRQTTM+33 -4YOY+30 -85Y+30 -810Y+26 -12

3.3 Fundamental Score

Let's check the fundamental score of IRadimed Corporation based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1536.684
Price to Book Ratio (EOD)Between0-18.881
Net Profit Margin (MRQ)Greater than00.276
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.285
Current Ratio (MRQ)Greater than19.213
Debt to Asset Ratio (MRQ)Less than10.115
Debt to Equity Ratio (MRQ)Less than10.130
Return on Equity (MRQ)Greater than0.150.061
Return on Assets (MRQ)Greater than0.050.054
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of IRadimed Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.965
Ma 20Greater thanMa 5055.750
Ma 50Greater thanMa 10052.636
Ma 100Greater thanMa 20049.246
OpenGreater thanClose55.500
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About IRadimed Corporation

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.

Fundamental data was last updated by Penke on 2025-01-28 20:31:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is fair priced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Iradimed earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Iradimed to the Medical Devices industry mean.
  • A Net Profit Margin of 27.6% means that €0.28 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of IRadimed Corporation:

  • The MRQ is 27.6%. The company is making a huge profit. +2
  • The TTM is 26.1%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ27.6%TTM26.1%+1.5%
TTM26.1%YOY25.8%+0.3%
TTM26.1%5Y20.3%+5.8%
5Y20.3%10Y20.5%-0.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ27.6%-6.8%+34.4%
TTM26.1%-14.6%+40.7%
YOY25.8%-14.5%+40.3%
5Y20.3%-15.3%+35.6%
10Y20.5%-14.5%+35.0%
4.3.1.2. Return on Assets

Shows how efficient Iradimed is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Iradimed to the Medical Devices industry mean.
  • 5.4% Return on Assets means that Iradimed generated €0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of IRadimed Corporation:

  • The MRQ is 5.4%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 5.1%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ5.4%TTM5.1%+0.2%
TTM5.1%YOY4.9%+0.2%
TTM5.1%5Y3.5%+1.6%
5Y3.5%10Y3.6%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ5.4%-2.3%+7.7%
TTM5.1%-3.2%+8.3%
YOY4.9%-3.9%+8.8%
5Y3.5%-2.7%+6.2%
10Y3.6%-3.1%+6.7%
4.3.1.3. Return on Equity

Shows how efficient Iradimed is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Iradimed to the Medical Devices industry mean.
  • 6.1% Return on Equity means Iradimed generated €0.06 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of IRadimed Corporation:

  • The MRQ is 6.1%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 6.0%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ6.1%TTM6.0%+0.1%
TTM6.0%YOY5.8%+0.2%
TTM6.0%5Y4.1%+1.9%
5Y4.1%10Y4.2%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ6.1%-2.9%+9.0%
TTM6.0%-3.9%+9.9%
YOY5.8%-4.0%+9.8%
5Y4.1%-4.0%+8.1%
10Y4.2%-4.9%+9.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of IRadimed Corporation.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Iradimed is operating .

  • Measures how much profit Iradimed makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Iradimed to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of IRadimed Corporation:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY14.8%-14.8%
TTM-5Y11.6%-11.6%
5Y11.6%10Y12.4%-0.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.2%+13.2%
TTM--21.7%+21.7%
YOY14.8%-12.8%+27.6%
5Y11.6%-16.3%+27.9%
10Y12.4%-13.5%+25.9%
4.3.2.2. Operating Ratio

Measures how efficient Iradimed is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 0.91 means that the operating costs are €0.91 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of IRadimed Corporation:

  • The MRQ is 0.910. The company is less efficient in keeping operating costs low.
  • The TTM is 0.930. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.910TTM0.930-0.020
TTM0.930YOY0.936-0.006
TTM0.9305Y1.024-0.095
5Y1.02410Y1.022+0.003
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9101.271-0.361
TTM0.9301.306-0.376
YOY0.9361.326-0.390
5Y1.0241.360-0.336
10Y1.0221.304-0.282
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of IRadimed Corporation.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Iradimed is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 9.21 means the company has €9.21 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of IRadimed Corporation:

  • The MRQ is 9.213. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.293. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ9.213TTM8.293+0.920
TTM8.293YOY8.993-0.700
TTM8.2935Y10.558-2.265
5Y10.55810Y10.523+0.035
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ9.2132.596+6.617
TTM8.2932.725+5.568
YOY8.9932.928+6.065
5Y10.5583.515+7.043
10Y10.5233.527+6.996
4.4.3.2. Quick Ratio

Measures if Iradimed is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Iradimed to the Medical Devices industry mean.
  • A Quick Ratio of 1.29 means the company can pay off €1.29 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of IRadimed Corporation:

  • The MRQ is 1.285. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.337. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.285TTM1.337-0.051
TTM1.337YOY1.585-0.249
TTM1.3375Y1.369-0.032
5Y1.36910Y1.395-0.026
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2851.478-0.193
TTM1.3371.598-0.261
YOY1.5851.892-0.307
5Y1.3692.415-1.046
10Y1.3952.550-1.155
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of IRadimed Corporation.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Iradimed assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Iradimed to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.11 means that Iradimed assets are financed with 11.5% credit (debt) and the remaining percentage (100% - 11.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of IRadimed Corporation:

  • The MRQ is 0.115. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.147. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.115TTM0.147-0.033
TTM0.147YOY0.147+0.000
TTM0.1475Y0.142+0.005
5Y0.14210Y0.143-0.001
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1150.399-0.284
TTM0.1470.403-0.256
YOY0.1470.369-0.222
5Y0.1420.428-0.286
10Y0.1430.449-0.306
4.5.4.2. Debt to Equity Ratio

Measures if Iradimed is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Iradimed to the Medical Devices industry mean.
  • A Debt to Equity ratio of 13.0% means that company has €0.13 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of IRadimed Corporation:

  • The MRQ is 0.130. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.176. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.130TTM0.176-0.047
TTM0.176YOY0.172+0.004
TTM0.1765Y0.166+0.010
5Y0.16610Y0.168-0.002
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1300.562-0.432
TTM0.1760.614-0.438
YOY0.1720.543-0.371
5Y0.1660.641-0.475
10Y0.1680.714-0.546
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Iradimed generates.

  • Above 15 is considered overpriced but always compare Iradimed to the Medical Devices industry mean.
  • A PE ratio of 28.57 means the investor is paying €28.57 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of IRadimed Corporation:

  • The EOD is 36.684. Based on the earnings, the company is overpriced. -1
  • The MRQ is 28.568. Based on the earnings, the company is overpriced. -1
  • The TTM is 29.035. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD36.684MRQ28.568+8.116
MRQ28.568TTM29.035-0.467
TTM29.035YOY27.702+1.333
TTM29.0355Y34.020-4.985
5Y34.02010Y33.646+0.374
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD36.684-1.449+38.133
MRQ28.568-1.755+30.323
TTM29.035-2.052+31.087
YOY27.702-2.976+30.678
5Y34.020-2.425+36.445
10Y33.646-2.069+35.715
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of IRadimed Corporation:

  • The EOD is 35.071. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 27.312. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 31.761. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD35.071MRQ27.312+7.759
MRQ27.312TTM31.761-4.449
TTM31.761YOY38.766-7.005
TTM31.7615Y46.144-14.383
5Y46.14410Y43.947+2.197
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD35.071-1.577+36.648
MRQ27.312-1.982+29.294
TTM31.761-2.233+33.994
YOY38.766-5.173+43.939
5Y46.144-3.969+50.113
10Y43.947-4.575+48.522
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Iradimed is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 6.92 means the investor is paying €6.92 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of IRadimed Corporation:

  • The EOD is 8.881. Based on the equity, the company is overpriced. -1
  • The MRQ is 6.916. Based on the equity, the company is overpriced. -1
  • The TTM is 6.952. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD8.881MRQ6.916+1.965
MRQ6.916TTM6.952-0.036
TTM6.952YOY6.785+0.167
TTM6.9525Y5.893+1.059
5Y5.89310Y5.849+0.044
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD8.8812.134+6.747
MRQ6.9162.234+4.682
TTM6.9522.408+4.544
YOY6.7852.955+3.830
5Y5.8934.245+1.648
10Y5.8494.579+1.270
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets94,247
Total Liabilities10,814
Total Stockholder Equity83,433
 As reported
Total Liabilities 10,814
Total Stockholder Equity+ 83,433
Total Assets = 94,247

Assets

Total Assets94,247
Total Current Assets74,286
Long-term Assets19,961
Total Current Assets
Cash And Cash Equivalents 51,721
Net Receivables 10,365
Inventory 11,252
Other Current Assets 949
Total Current Assets  (as reported)74,286
Total Current Assets  (calculated)74,286
+/-0
Long-term Assets
Property Plant Equipment 14,420
Intangible Assets 2,892
Long-term Assets Other 184
Long-term Assets  (as reported)19,961
Long-term Assets  (calculated)17,496
+/- 2,465

Liabilities & Shareholders' Equity

Total Current Liabilities8,063
Long-term Liabilities2,751
Total Stockholder Equity83,433
Total Current Liabilities
Accounts payable 1,401
Other Current Liabilities 250
Total Current Liabilities  (as reported)8,063
Total Current Liabilities  (calculated)1,651
+/- 6,412
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt264
Long-term Liabilities  (as reported)2,751
Long-term Liabilities  (calculated)264
+/- 2,487
Total Stockholder Equity
Retained Earnings 53,545
Total Stockholder Equity (as reported)83,433
Total Stockholder Equity (calculated)53,545
+/- 29,887
Other
Capital Stock1
Common Stock Shares Outstanding 12,670
Net Invested Capital 83,433
Net Working Capital 66,223
Property Plant and Equipment Gross 18,880



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
> Total Assets 
62,571
66,729
68,368
68,825
70,425
71,067
72,189
75,580
78,399
82,881
72,393
75,724
79,544
85,513
75,620
81,431
87,406
92,156
88,014
89,949
94,247
94,24789,94988,01492,15687,40681,43175,62085,51379,54475,72472,39382,88178,39975,58072,18971,06770,42568,82568,36866,72962,571
   > Total Current Assets 
55,513
58,964
60,511
60,085
62,904
63,736
65,213
68,637
71,589
76,245
65,514
68,495
71,873
77,490
61,298
66,091
71,931
76,001
71,886
73,578
74,286
74,28673,57871,88676,00171,93166,09161,29877,49071,87368,49565,51476,24571,58968,63765,21363,73662,90460,08560,51158,96455,513
       Cash And Cash Equivalents 
38,637
43,482
44,636
45,458
47,550
50,069
50,802
55,160
58,372
62,000
50,446
52,158
55,592
57,961
42,777
45,823
46,745
49,762
45,127
48,535
51,721
51,72148,53545,12749,76246,74545,82342,77757,96155,59252,15850,44662,00058,37255,16050,80250,06947,55045,45844,63643,48238,637
       Short-term Investments 
3,927
2,768
2,782
2,326
2,320
1,909
1,903
949
945
502
500
0
0
0
0
0
0
0
0
0
0
00000000005005029459491,9031,9092,3202,3262,7822,7683,927
       Net Receivables 
6,925
7,293
5,852
4,506
4,252
4,575
4,564
3,885
4,254
5,137
6,513
8,382
10,651
13,275
11,533
11,082
12,783
12,224
13,027
11,953
10,365
10,36511,95313,02712,22412,78311,08211,53313,27510,6518,3826,5135,1374,2543,8854,5644,5754,2524,5065,8527,2936,925
       Inventory 
4,351
3,642
4,215
4,869
4,590
3,934
4,641
4,468
4,433
4,300
4,345
4,857
5,243
5,369
6,312
8,415
11,668
12,821
12,696
12,071
11,252
11,25212,07112,69612,82111,6688,4156,3125,3695,2434,8574,3454,3004,4334,4684,6413,9344,5904,8694,2153,6424,351
   > Long-term Assets 
7,059
7,765
7,857
8,740
7,522
7,331
6,976
6,942
6,809
6,636
6,879
7,229
7,671
7,323
14,322
15,340
15,475
16,155
16,129
16,371
19,961
19,96116,37116,12916,15515,47515,34014,3227,3237,6717,2296,8796,6366,8096,9426,9767,3317,5228,7407,8577,7657,059
       Property Plant Equipment 
0
5,010
4,997
5,064
4,941
4,835
4,779
4,707
4,659
4,551
4,564
4,581
4,569
2,400
10,991
10,968
11,034
11,332
11,390
10,845
14,420
14,42010,84511,39011,33211,03410,96810,9912,4004,5694,5814,5644,5514,6594,7074,7794,8354,9415,0644,9975,0100
       Intangible Assets 
825
860
901
937
976
961
976
1,010
1,055
1,119
1,335
1,543
1,881
2,069
2,205
2,354
2,459
2,519
2,670
2,748
2,892
2,8922,7482,6702,5192,4592,3542,2052,0691,8811,5431,3351,1191,0551,010976961976937901860825
       Long-term Assets Other 
208
232
267
246
258
262
236
233
226
201
172
201
236
4,923
503
252
178
181
185
188
184
1841881851811782525034,923236201172201226233236262258246267232208
> Total Liabilities 
10,798
11,204
10,307
10,461
9,709
9,682
9,111
10,677
10,507
10,708
9,845
9,825
9,773
11,841
11,280
12,433
12,838
20,736
11,893
10,278
10,814
10,81410,27811,89320,73612,83812,43311,28011,8419,7739,8259,84510,70810,50710,6779,1119,6829,70910,46110,30711,20410,798
   > Total Current Liabilities 
5,653
5,859
4,880
5,254
4,760
4,917
4,635
6,297
6,320
6,823
6,249
6,138
5,604
8,554
6,756
7,586
7,882
16,327
7,617
7,458
8,063
8,0637,4587,61716,3277,8827,5866,7568,5545,6046,1386,2496,8236,3206,2974,6354,9174,7605,2544,8805,8595,653
       Accounts payable 
1,174
994
873
704
580
657
618
668
843
783
1,137
822
964
1,799
1,756
2,552
2,783
1,857
1,285
1,121
1,401
1,4011,1211,2851,8572,7832,5521,7561,7999648221,1377838436686186575807048739941,174
       Other Current Liabilities 
108
2,458
2,139
2,609
2,162
2,290
2,524
3,351
2,791
2,949
2,954
2,762
2,000
3,589
250
2,287
250
250
250
250
250
2502502502502502,2872503,5892,0002,7622,9542,9492,7913,3512,5242,2902,1622,6092,1392,458108
   > Long-term Liabilities 
5,145
5,345
5,426
5,206
4,948
4,765
4,476
4,380
4,187
3,885
3,596
3,687
4,169
3,287
4,524
4,847
4,956
4,409
4,276
2,820
2,751
2,7512,8204,2764,4094,9564,8474,5243,2874,1693,6873,5963,8854,1874,3804,4764,7654,9485,2065,4265,3455,145
       Capital Lease Obligations Min Short Term Debt
3,014
2,956
2,897
2,837
2,777
2,715
2,653
2,614
2,549
2,482
2,414
2,346
2,276
2,205
2,348
2,248
2,146
2,043
1,938
372
264
2643721,9382,0432,1462,2482,3482,2052,2762,3462,4142,4822,5492,6142,6532,7152,7772,8372,8972,9563,014
       Other Liabilities 
0
2,630
2,774
2,617
2,424
2,305
2,083
2,034
1,911
1,679
1,462
1,626
2,182
1,375
0
3,013
0
0
0
0
0
000003,01301,3752,1821,6261,4621,6791,9112,0342,0832,3052,4242,6172,7742,6300
> Total Stockholder Equity
51,773
55,524
58,061
58,364
60,716
61,385
63,078
64,902
67,891
72,174
62,548
65,899
69,771
73,672
64,340
68,998
74,568
71,420
76,121
79,671
83,433
83,43379,67176,12171,42074,56868,99864,34073,67269,77165,89962,54872,17467,89164,90263,07861,38560,71658,36458,06155,52451,773
   Common Stock
0
1
1
1
1
1
1
1
1
1
1
1
1
1
0
1
0
0
0
0
0
000001011111111111110
   Retained Earnings 
33,059
36,300
38,070
35,957
37,032
37,669
39,056
40,526
43,102
46,995
36,923
40,164
43,591
47,264
37,447
41,627
46,694
43,258
47,395
50,396
53,545
53,54550,39647,39543,25846,69441,62737,44747,26443,59140,16436,92346,99543,10240,52639,05637,66937,03235,95738,07036,30033,059
   Capital Surplus 000000000000000000000
   Treasury Stock000000000000000000000
   Other Stockholders Equity 
0
30
41
54
47
37
32
24
21
17
6
0
0
0
0
0
0
0
0
0
0
000000000061721243237475441300



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in EUR. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue65,562
Cost of Revenue-15,404
Gross Profit50,15850,158
 
Operating Income (+$)
Gross Profit50,158
Operating Expense-45,527
Operating Income20,0354,631
 
Operating Expense (+$)
Research Development2,859
Selling General Administrative27,264
Selling And Marketing Expenses-
Operating Expense45,52730,123
 
Net Interest Income (+$)
Interest Income1,864
Interest Expense--
Other Finance Cost-0
Net Interest Income1,864
 
Pretax Income (+$)
Operating Income20,035
Net Interest Income1,864
Other Non-Operating Income Expenses-
Income Before Tax (EBT)21,73820,197
EBIT - interestExpense = 0
17,193
17,193
Interest Expense-
Earnings Before Interest and Taxes (EBIT)-21,738
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax21,738
Tax Provision-4,545
Net Income From Continuing Ops17,19317,193
Net Income17,193
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-161-1,864
 

Technical Analysis of Iradimed
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Iradimed. The general trend of Iradimed is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Iradimed's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of IRadimed Corporation.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: .

The bearish price targets are: 52.84 > 52.50 > 52.50.

Tweet this
IRadimed Corporation Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of IRadimed Corporation. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

IRadimed Corporation Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of IRadimed Corporation. The current macd is 1.34640371.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Iradimed price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Iradimed. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Iradimed price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
IRadimed Corporation Daily Moving Average Convergence/Divergence (MACD) ChartIRadimed Corporation Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of IRadimed Corporation. The current adx is 48.96.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Iradimed shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
IRadimed Corporation Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of IRadimed Corporation. The current sar is 59.50.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
IRadimed Corporation Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of IRadimed Corporation. The current rsi is 56.96. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
IRadimed Corporation Daily Relative Strength Index (RSI) ChartIRadimed Corporation Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of IRadimed Corporation. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Iradimed price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
IRadimed Corporation Daily Stochastic Oscillator ChartIRadimed Corporation Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of IRadimed Corporation. The current cci is 33.98.

IRadimed Corporation Daily Commodity Channel Index (CCI) ChartIRadimed Corporation Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of IRadimed Corporation. The current cmo is 8.37618015.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
IRadimed Corporation Daily Chande Momentum Oscillator (CMO) ChartIRadimed Corporation Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of IRadimed Corporation. The current willr is -66.66666667.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Iradimed is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
IRadimed Corporation Daily Williams %R ChartIRadimed Corporation Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of IRadimed Corporation.

IRadimed Corporation Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of IRadimed Corporation. The current atr is 1.00905537.

IRadimed Corporation Daily Average True Range (ATR) ChartIRadimed Corporation Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of IRadimed Corporation. The current obv is -116.

IRadimed Corporation Daily On-Balance Volume (OBV) ChartIRadimed Corporation Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of IRadimed Corporation. The current mfi is 100.00.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
IRadimed Corporation Daily Money Flow Index (MFI) ChartIRadimed Corporation Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for IRadimed Corporation.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-09-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-25STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-30STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-11STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-16BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-10-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-11STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-11-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-26MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-02ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-03ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-12STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-12-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-03BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-01-06STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-01-21ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-24MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-01-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-02-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside

6.3. Candlestick Patterns

IRadimed Corporation Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of IRadimed Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.965
Ma 20Greater thanMa 5055.750
Ma 50Greater thanMa 10052.636
Ma 100Greater thanMa 20049.246
OpenGreater thanClose55.500
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Iradimed with someone you think should read this too:
  • Are you bullish or bearish on Iradimed? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Iradimed? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about IRadimed Corporation

I send you an email if I find something interesting about IRadimed Corporation.


Comments

How you think about this?

Leave a comment

Stay informed about IRadimed Corporation.

Receive notifications about IRadimed Corporation in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.